Olanzapine in the acute treatment of bipolar I disorder with a history of rapid cycling

Journal of Affective Disorders

Volumn 73, Issue 1-2, 2003, Pages 155-161

  Sanger, Todd M ^a   Tohen, Mauricio ^a,b   Vieta, Eduard ^c   Dunner, David L ^d   Bowden, Charles L ^e   Calabrese, Joseph R ^f   Feldman, Peter D ^a   Jacobs, Thomas G ^a   Breier, Alan ^a  

^a ELI LILLY AND COMPANY   (United States)

^b MCLEAN HOSPITAL   (United States)

^c UNIVERSITY OF BARCELONA   (Spain)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^f CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Bipolar disorder; Mania; Olanzapine; Rapid cycling

Indexed keywords

NEUROLEPTIC AGENT; OLANZAPINE; PLACEBO;

ADULT; AGITATION; ANXIETY DISORDER; APATHY; ARTICLE; ASTHENIA; BIPOLAR I DISORDER; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DRUG EFFICACY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HEADACHE; HOSTILITY; HUMAN; INCREASED APPETITE; MALE; MENSTRUATION DISORDER; MENTAL PATIENT; MUSCLE HYPERTONIA; NERVOUSNESS; OUTCOMES RESEARCH; PAIN; PRIORITY JOURNAL; RATING SCALE; RHINITIS; SIDE EFFECT; SINUSITIS; SOMNOLENCE; STATISTICAL SIGNIFICANCE; TREATMENT WITHDRAWAL; VERTIGO; WEIGHT GAIN; XEROSTOMIA;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BIPOLAR DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIODICITY; PIRENZEPINE; PLACEBO EFFECT; PLACEBOS; RETROSPECTIVE STUDIES;

EID: 0037222247     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(02)00334-8     Document Type: Article

References (30)

1. Altshuler L.L., Post R.M., Leverich G.S., Mikalauskas K., Rosoff A., Ackerman L. Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am. J. Psychiatry. 152:1995;1130-1138.
2. Baldessarini R.J., Tondo L., Floris G., Hennen J. Effects of rapid cycling on response to lithium maintenance treatment in 360 bipolar I and II disorder patients. J. Affect. Disord. 61:2000;13-22.
3. Barnes T.R. A rating scale for drug-induced akathisia. Br. J. Psychiatry. 154:1989;672-676.
4. Bauer M.S., Calabrese J., Dunner D.L., Post R., Whybrow P.C., Gyulai L., Tay L.K., Younkin S.R., Bynum D., Lavori P. Multisite data reanalysis of the validity of rapid cycling as a course modifier for bipolar disorder in DSM-IV. Am. J. Psychiatry. 151:1994;506-515.
5. Calabrese J.R., Delucchi G.A. Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder. Am. J. Psychiatry. 147:1990;431-434.
6. Calabrese J.R., Kimmel S.E., Woyshville M.J., Rapport D.J., Faust C.J., Thompson P.A., Meltzer H.Y. Clozapine for treatment-refractory mania. Am. J. Psychiatry. 153:1996;759-764.
7. Calabrese J.R., Markovitz P.J., Kimmel S.E., Wagner S.C. Spectrum of efficacy of valproate in 78 rapid-cycling bipolar patients. J. Clin. Psychopharmacol. 12:1992;53S-56S.
8. Calabrese J.R., Meltzer H.Y., Markovitz P.J. Clozapine prophylaxis in rapid cycling bipolar disorder. J. Clin. Psychopharmacol. 11:1991;396-397.
9. Calabrese J.R., Rapport D.J., Findling R.L., Shelton M.D., Kimmel S.E. Rapid-cycling bipolar disorder. Marneros A., Angst J. Bipolar Disorders. 100 Years After Manic-Depressive Insanity. 2000;89-109 Kluwer, Amsterdam.
10. Dunner D.L., Fieve R.R. Clinical factors in lithium carbonate prophylaxis failure. Arch. Gen. Psychiatry. 30:1974;229-233.
11. Dunner D.L., Patrick V., Fieve R.R. Rapid cycling manic depressive patients. Compr. Psychiatry. 18:1977;561-565.
12. Fatemi S.H., Rapport D.J., Calabrese J.R., Thuras P. Lamotrigine in rapid-cycling bipolar disorder. J. Clin. Psychiatry. 58:1997;522-527.
13. Fawcett J., Scheftner W., Clark D., Hedeker D., Gibbons R., Coryell W. Clinical predictors of suicide in patients with major affective disorders: a controlled prospective study. Am. J. Psychiatry. 144:1987;35-40.
14. Gillings D., Koch G. The application of the principle of intention-to-treat to the analysis of clinical trials. Drug Info. J. 25:1991;411-425.
15. Guy W. ECDEU Assessment Manual for Psychopharmacology, Revised. 1976;US Department of Health, Education, and Welfare, Bethesda, MD.
16. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 23:1960;56-62.
17. Jacobsen F.M. Risperidone in the treatment of affective illness and obsessive-compulsive disorder. J. Clin. Psychiatry. 56:1995;423-429.
18. Kukopoulos A., Reginaldi D., Laddomada P., Floris G., Serra G., Tondo L. Course of the manic depressive cycle and changes caused by treatment. Pharmacopsychiatria. 13:1980;156-167.
19. McElroy S.L., Frye M.A., Denicoff K.D., Altshuler L.L., Nolen W., Kupka R., Suppes T., Keck P.E. Jr., Leverich G.S., Kmetz G.F., Post P.M. Olanzapine in treatment-resistant bipolar disorder. J. Affect. Disord. 49:1998;119-122.
20. McElroy S.L., Keck P.E. Jr., Pope H.G. Jr., Hudson J.I. Valproate in the treatment of rapid cycling bipolar disorder. J. Clin. Psychopharmacol. 8:1988;275-279.
21. McElroy S.L., Keck P.E. Jr., Strakowski S.M. Mania, psychosis, and antipsychotics. J. Clin. Psychiatry. 57:1996;14-26.
22. Post R.M. Use of the anticonvulsant carbamazepine in primary and secondary affective illness: clinical and theoretical implications. Psychol. Med. 12:1982;70-104.
23. Post R.M., Uhde T.W., Roy-Byrne P.P., Joffe R.T. Correlates of antimanic response to carbamazepine. Psychiatry Res. 21:1987;71-83.
24. Simpson G.M., Angus J.W.S. A rating scale for extrapyramidal side effects. Acta Psychiatr. Scand. 212:1970;S11-S19.
25. Spearing M.K., Post P.M., Leverich G.S., Brandt D., Nolen W. Modification of the Clinical Global Impressions (CGI) scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res. 73:1997;159-171.
26. Tohen M., Sanger T.M., McElroy S.L., Tollefson G.D., Chengappa K.N.R., Daniel D.G., Petty F., Centorrino F., Wang R., Grundy S.L., Greaney M.G., Jacobs T.G., David S.R., Toma V. Olanzapine versus placebo in the treatment of acute mania. Am. J. Psychiatry. 156:1999;702-709.
27. Tollefson G.D., Beasley C.M. Jr., Tran P.V., Street J.S., Krueger J.A., Tamura R.N., Graffeo K.A., Thieme M.E. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial. Am. J. Psychiatry. 154:1997;457-465.
28. Vieta E., Gasto C., Colom F., Martinez A., Otero A., Vallejo J. Treatment of refractory rapid cycling bipolar disorder with risperidone. J. Clin. Psychopharmacol. 18:1998;172-174.
29. Vieta E., Parramon G., Padrell E., Nieto E., Martínez-Arán A., Corbella B., Colom F., Reinares M., Goikolea J.M., Torrent C. Quetiapine in the treatment of rapid cycling bipolar disorder. Bipolar Disorder. 4:2002;335-340.
30. Young R.C., Biggs J.T., Ziegler V.E., Meyer D.A. A rating scale for mania: reliability, validity, and sensitivity. Br. J. Psychiatry. 133:1978;429-435.